Chemical formula: C₂₃H₃₂F₃N₅O₄ Molecular mass: 499.535 g/mol
Nirmatrelvir (drug development code: PF-07321332), is a potent and selective peptidomimetic inhibitor of the SARS-CoV-2 3-chymotrypsin like protease, a virally encoded enzyme that is critical to the SARS-CoV-2 replication cycle.
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| PAXLOVID Film-coated tablet | European Medicines Agency (EU) | MPI, EU: SmPC |
Nirmatrelvir is an active ingredient of these brands:
United States (US)
Australia (AU)
Austria (AT)
Canada (CA)
Croatia (HR)
Estonia (EE)
Finland (FI)
France (FR)
Ireland (IE)
Italy (IT)
Japan (JP)
Lithuania (LT)
New Zealand (NZ)
Poland (PL)
Romania (RO)
Spain (ES)
United Kingdom (UK)
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
